Guidance
Evidence-based recommendations on transurethral laser ablation for recurrent non-muscle-invasive bladder cancer in adults. This involves using a laser inserted into the bladder to destroy the cancer cells.
Is this guidance up to date?
Next review: July 2022
Guidance development process
How we develop NICE interventional procedures guidance
Coding and clinical classification codes for this guidance